Pittsburgh, PA, United States of America

Mark Derdzinski

USPTO Granted Patents = 6 

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Mark Derdzinski: Innovator in Glucose Monitoring Technology

Introduction

Mark Derdzinski, an inventive mind from Pittsburgh, PA, has made significant strides in the field of glucose monitoring technology. With a total of five patents, his work primarily focuses on enhancing the accuracy and predictive capabilities of continuous glucose monitoring systems.

Latest Patents

Derdzinski's latest innovations include groundbreaking patents aimed at revolutionizing glucose measurement predictions using stacked machine learning models. This patent describes a Continuous Glucose Monitoring (CGM) platform that incorporates several machine learning models, where the output generated by one model serves as input for another. The stacked models not only predict glucose measurements but also forecast glucose-impacting events for a specified future time interval. Another notable patent covers glucose prediction using machine learning combined with time series glucose measurements, leveraging extensive datasets from wearable glucose monitoring devices to make accurate predictions based on historical user data.

Career Highlights

Currently, Mark Derdzinski is affiliated with Dexcom, Inc., a prominent player in the health tech industry, known for its advanced glucose monitoring systems. His innovative contributions have helped refine technology aimed at improving the lives of individuals managing diabetes by providing them with timely and accurate glucose data.

Collaborations

Throughout his career, Derdzinski has worked alongside notable colleagues, including Joost Herman Van Der Linden and Andrew Scott Parker. Their collaboration reflects the importance of teamwork in driving technological advancements and finding effective solutions for health-related challenges.

Conclusion

Mark Derdzinski stands out in the realm of medical technology with his impressive portfolio of patents and his role in advancing glucose monitoring systems. His work exemplifies how innovation can lead to meaningful improvements in healthcare, particularly for individuals living with diabetes. As technology continues to evolve, contributions like those of Derdzinski are essential for enhancing the quality of life for many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…